CN1183962A - 痤疮灵药水 - Google Patents
痤疮灵药水 Download PDFInfo
- Publication number
- CN1183962A CN1183962A CN 97114483 CN97114483A CN1183962A CN 1183962 A CN1183962 A CN 1183962A CN 97114483 CN97114483 CN 97114483 CN 97114483 A CN97114483 A CN 97114483A CN 1183962 A CN1183962 A CN 1183962A
- Authority
- CN
- China
- Prior art keywords
- gram
- liquid medicine
- acne
- diethylstilbestrol
- tween
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及一种痤疮药水,是将氮铜与吐温-80混合研磨乳化后添加数味药研磨混均,再加入注射用水及香精调制成药水,其特征在于:所述的数味药包括:甲硝唑、乙底酚、甲氰米胍、维A酸、硼酸粉。本发明用于治疗痤疮,疗效好,且用后患处不留疤痕,无任何副作用。
Description
本发明涉及一种外搽药水,确切地说是一种痤疮药水。
痤疮是一种常见的多发病,人们特别是青年人患后不仅影响工作、学习,而且有损美貌。为了治疗这种病,目前人们已研制出多种外用药,虽有一定疗效,但因都为霜剂或膏剂,搽在患处常易将毛囊孔阻塞,影响体内渗出物的排泄,从而影响药物吸收,疗效差。
本发明的目的提供一种疗效好,用后患处不留疤痕且无任何不适感的痤疮药水。
本发明的目的是由以下技术方案实现的。
本发明是将氮铜与吐温-80混合研磨乳化后添加数味药研磨混均,再加入注射用水及香精调制成药水,其特征在于:所述的数味药包括;甲硝唑,乙底酚、甲氰米胍、维A酸、硼酸粉。
药水配方为
氮铜 0.3~1%
吐温-80 0.3~1%
甲硝唑 0.5~1%
乙底酚 0.004~0.01%
甲氰米胍 0.5~3%
维A酸 0.5~2%
硼酸粉 0.5~1%
本发明的优点是由于甲氰咪胍具有抗雄性激素作用,从而可控制皮脂腺活性减少皮脂的产生,减少毛囊管腔的角化物堆积;乙底粉具有增进女性激素的作用;甲硝唑具有较强的杀灭和抑制厌氧菌作用,因此用其配制的药水疗效好且治愈后无疤痕,无任何付作用。
本发明的另一优点是配制简单,成本低廉,利于推广。
以下通过实施例,对本发明作进一步地描述。
实施例1:
取1毫升氮铜和1毫升吐温-80,将其混合研磨乳化后添加0.5克甲硝唑,0.006克乙底酚,0.5克甲氰米胍,0.5克维A酸,0.5克硼酸粉研磨混均,再加入注射用水,使其总量为100毫升,最后添加适量香精,调制成药水后封装使用。
实施例2:
取0.3毫升氮铜和0.3毫升吐温-80,将其混合研磨乳化后添加1克甲硝唑,0.004克乙底酚,3克甲氰米胍,2克维A酸,1克硼酸粉研磨混均,再加入注射用水,使其总量为100毫升,最后添加适量香精,调制成药水后封装使用。
实施例3:
取0.6毫升氮铜和0.6毫升吐温-80,将其混合研磨乳化后添加0.7克甲硝唑,0.01克乙底酚,2克甲氰米胍,1克维A酸,0.8克硼酸粉研磨混均,再加入注射用水,使其总量为100毫升,最后添加适量香精,调制成药水后封装使用。
实施例4:
取0.8毫升氮铜和0.8毫升吐温-80,将其混合研磨乳化后添加0.8克甲硝唑,0.004克乙底酚,2克甲氰米胍,1克维A酸,0.8克硼酸粉研磨混均,再加入注射用水,使其总量为100毫升,最后添加适量香精,调制成药水后封装使用。
Claims (2)
1、一种痤疮药水,是将氮铜与吐温-80混合研磨乳化后添加数味药研磨混均,再加入注射用水及香精调制成药水,其特征在于:所述的数味药包括:甲硝唑、乙底酚、甲氰米胍、维A酸、硼酸粉。
2、根据权利要求1所述的痤疮药水,其特征在于:所述的药水配方为
氮铜 0.3~1%
吐温-80 0.3~1%
甲硝唑 0.5~1%
乙底酚 0.004~0.01%
甲氰米胍 0.5~3%
维A酸 0.5~2%
硼酸粉 0.5~1%
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 97114483 CN1183962A (zh) | 1997-08-28 | 1997-08-28 | 痤疮灵药水 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 97114483 CN1183962A (zh) | 1997-08-28 | 1997-08-28 | 痤疮灵药水 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1183962A true CN1183962A (zh) | 1998-06-10 |
Family
ID=5172983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 97114483 Pending CN1183962A (zh) | 1997-08-28 | 1997-08-28 | 痤疮灵药水 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1183962A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1090936C (zh) * | 1999-05-19 | 2002-09-18 | 张广政 | 一种治疗痤疮的复合制剂 |
WO2012001338A1 (en) * | 2010-07-01 | 2012-01-05 | Kartar Singh Lalvani | Composition for the treatment of acne vulgaris |
-
1997
- 1997-08-28 CN CN 97114483 patent/CN1183962A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1090936C (zh) * | 1999-05-19 | 2002-09-18 | 张广政 | 一种治疗痤疮的复合制剂 |
WO2012001338A1 (en) * | 2010-07-01 | 2012-01-05 | Kartar Singh Lalvani | Composition for the treatment of acne vulgaris |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0787005B1 (en) | Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation | |
US6071543A (en) | Pyridine-thiols reverse mucocutaneous aging | |
EP1047399B1 (en) | Skin care composition | |
US6667045B2 (en) | Topical applications for skin treatment | |
US5710141A (en) | Method for treating skin wrinkles | |
EP2286809A1 (en) | Personalised pharmaceutical composition containing retinoic acid, for anti-aging of the skin | |
US20060013845A1 (en) | Oxygenated personal care products | |
CN109745261B (zh) | 一种头皮护理液及其制备方法 | |
EP1565189A1 (en) | Anti-aging skin care composition and uses thereof | |
US20060024339A1 (en) | Methods of managing the redness associated with a dermatological condition | |
WO2003026639A1 (en) | Novel compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use | |
IL129272A (en) | Preparation for the treatment and treatment of skin damage and its preparation | |
PH12009000168A1 (en) | Stabilized compositions containing an oxygen-labile active agent | |
CN113134088B (zh) | 一种含有生物多糖的组合物及其应用 | |
CN101489541A (zh) | 多胺在治疗银屑病中的应用 | |
US20030165577A1 (en) | Novel compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use | |
KR20110074513A (ko) | 피부 감염의 국소 치료법 | |
CA2776702A1 (en) | Topical dapsone for the treatment of acne | |
JP2000038340A (ja) | 育毛剤および食品 | |
Happle et al. | Systemic retinoid therapy of systematized verrucous epidermal nevus | |
CN1183962A (zh) | 痤疮灵药水 | |
CN103479661B (zh) | 一种祛痘美容药 | |
US7198807B2 (en) | Inhibition of P. acnes using botanical extracts | |
US5240945A (en) | Method and compositions for treating acne | |
KR100202058B1 (ko) | 혼합미백제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
C10 | Entry into substantive examination | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |